BCL2 and neoplasm: Furthermore, the present study confirmed that the TCM FYD could effectively inhibit the potential tumorigenicity of BMSCs in mice, and that BMSCs expressing the IL-12 gene had a targeted antitumor effect based on TUNEL staining, tumor volume and body weight changes, serum IL-12 levels, and Bax/Bcl-2 expression.